A Multimodal Study of the Relationship Between Exposure to Endocrine Disruptors and Occurrence of Hypospadias - HYPOLLUT

ConditionHypospadias
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1+
SponsorUniversity Hospital, Montpellier

About this trial

This study aims to demonstrate the impact of Endocrine-Disrupting Chemicals (EDCs) on the risk of hypospadias incidence. It is a multicenter comparative case-control study, involving two groups. The first group consists of biological mothers who have given birth to children with hypospadias (Case Group), while the second group consists of biological mothers who have given birth to children without any malformations (Control Group). Through an integrative approach that combines a direct toxicological study of numerous pollutants present during pregnancy, and a comprehensive exposome assessment using validated tools, this study can significantly enhance our understanding and prevention of this malformation.

Eligibility criteria

Qualifiers

Parents of legal age having signed a free and informed consent for the participation of their child

Biological mother of a boy aged between 1 and 6 months

Biological mother with a minimum hair length of 18 cm

Biological mother who has signed a free and informed consent for her participation

Disqualifiers

Child with another congenital anomaly or malformative syndrome

Child with an endocrine pathology

Biological mother or child under legal protection, guardianship, or curatorship

Biological mother or child in the exclusion period of a previous study

Trial design

Treatments tested in this trial

  • Consultation visit (Visit 1)
  • Consultation visit (Visit 1)

Treatment groups

200 Participants
are divided into 2 treatment groups